CS060304

· Cascade Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CS060304, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects [Phase 1]

See pricing